The 5-Cog paradigm to improve detection of cognitive impairment and dementia: clinical trial protocol.
Rachel ChalmerEmmeline AyersErica F WeissRubina MalikAmy EhrlichCuiling WangJessica ZwerlingAsif AnsariKatherine L PossinJoe VerghesePublished in: Neurodegenerative disease management (2022)
Cognitive impairment related to dementia is under-diagnosed in primary care despite availability of numerous cognitive assessment tools; under-diagnosis is more prevalent for members of racial and ethnic minority groups. Clinical decision-support systems may improve rates of primary care providers responding to positive cognitive assessments with appropriate follow-up. The 5-Cog study is a randomized controlled trial in 1200 predominantly Black and Hispanic older adults from an urban underserved community who are presenting to primary care with cognitive concerns. The study will validate a novel 5-minute cognitive assessment coupled with an electronic medical record-embedded decision tree to overcome the barriers of current cognitive assessment paradigms in primary care and facilitate improved dementia care.
Keyphrases
- phase ii
- primary care
- clinical trial
- cognitive impairment
- mild cognitive impairment
- double blind
- placebo controlled
- clinical decision support
- healthcare
- general practice
- palliative care
- randomized controlled trial
- mental health
- african american
- physical activity
- electronic health record
- chronic pain
- label free
- pain management